Royal Bank of Canada’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5
| Closed | – | – | 7945 |
|
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 7716 |
|
|
2022
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 8031 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 8114 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 7983 |
|
|
2022
Q1 | $0 | Sell |
5
-11
| -69% | -$18 | ﹤0.01% | 8178 |
|
|
2021
Q4 | $0 | Buy |
16
+11
| +220% | +$22 | ﹤0.01% | 8063 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 7999 |
|
|
2021
Q2 | $0 | Buy |
+5
| New | +$16 | ﹤0.01% | 7801 |
|
|
2020
Q2 | – | Sell |
-200
| Closed | -$1K | – | 7028 |
|
|
2020
Q1 | $1K | Sell |
200
-300
| -60% | -$3.22K | ﹤0.01% | 6541 |
|
|
2019
Q4 | $6K | Hold |
500
| – | – | ﹤0.01% | 6320 |
|
|
2019
Q3 | $5K | Sell |
500
-151
| -23% | -$1.97K | ﹤0.01% | 6067 |
|
|
2019
Q2 | $12K | Buy |
651
+500
| +331% | +$13.5K | ﹤0.01% | 5977 |
|
|
2019
Q1 | $5K | Sell |
151
-50
| -25% | -$1.67K | ﹤0.01% | 6295 |
|
|
2018
Q4 | $5K | Sell |
201
-273
| -58% | -$12.1K | ﹤0.01% | 6187 |
|
|
2018
Q3 | $29K | Sell |
474
-732
| -61% | -$49.6K | ﹤0.01% | 5506 |
|
|
2018
Q2 | $89K | Buy |
1,206
+480
| +66% | +$37.4K | ﹤0.01% | 4867 |
|
|
2018
Q1 | $47K | Buy |
726
+320
| +79% | +$24.2K | ﹤0.01% | 5084 |
|
|
2017
Q4 | $34K | Buy |
406
+19
| +5% | +$1.86K | ﹤0.01% | 5357 |
|
|
2017
Q3 | $44K | Buy |
387
+223
| +136% | +$23.5K | ﹤0.01% | 5490 |
|
|
2017
Q2 | $19K | Sell |
164
-56
| -25% | -$6.95K | ﹤0.01% | 5567 |
|
|
2017
Q1 | $28K | Buy |
220
+218
| +10,900% | +$28.6K | ﹤0.01% | 5461 |
|
|
2016
Q4 | $0 | Sell |
2
-18
| -90% | -$3.2K | ﹤0.01% | 6844 |
|
|
2016
Q3 | $4K | Buy |
+20
| New | +$3.44K | ﹤0.01% | 6044 |
|
|
2015
Q4 | – | Sell |
-182
| Closed | -$27K | – | 6888 |
|
|
2015
Q3 | $27K | Buy |
182
+131
| +257% | +$24K | ﹤0.01% | 5442 |
|
|
2015
Q2 | $11K | Buy |
51
+31
| +155% | +$7.6K | ﹤0.01% | 6011 |
|
|
2015
Q1 | $5K | Buy |
+20
| New | +$4.84K | ﹤0.01% | 5751 |
|
Other funds holding BLCM
BC
BRWA
TCM
PGAM
Royal Bank of Canada's BLCM Position: Q2 2023 in Review
Royal Bank of Canada sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 5 shares.
Royal Bank of Canada first reported a position in BLCM in Q1 2015 and held it in 26 quarters. The position peaked at $89K in Q2 2018. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.
- Royal Bank of Canada reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Royal Bank of Canada sold 5 Bellicum Pharmaceuticals, Inc. shares in Q2 2023.
- Royal Bank of Canada first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 26 quarters.
- Royal Bank of Canada's Bellicum Pharmaceuticals, Inc. position peaked at $89K in Q2 2018.
- 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.